| 000 | 01175 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517111657.0 | ||
| 264 | 0 | _c20181017 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a2055-6845 | ||
| 024 | 7 |
_a10.1093/ehjcvp/pvw022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOvervad, Thure Filskov | |
| 245 | 0 | 0 |
_aTreatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score. _h[electronic resource] |
| 260 |
_bEuropean heart journal. Cardiovascular pharmacotherapy _c01 2017 |
||
| 300 |
_a37-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
| 650 | 0 | 4 |
_aCause of Death _xtrends |
| 650 | 0 | 4 | _aGlobal Health |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aStroke _xepidemiology |
| 650 | 0 | 4 |
_aSurvival Rate _xtrends |
| 700 | 1 | _aNielsen, Peter Brønnum | |
| 700 | 1 | _aLip, Gregory Y H | |
| 773 | 0 |
_tEuropean heart journal. Cardiovascular pharmacotherapy _gvol. 3 _gno. 1 _gp. 37-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/ehjcvp/pvw022 _zAvailable from publisher's website |
| 999 |
_c26324310 _d26324310 |
||